AC Immune Earnings Estimates, EPS & Revenue | NASDAQ:ACIU

Comments

AC Immune SA Earnings Estimates

ACIUNASDAQ

Trade with Public

$3.02

0.0150.50%

At close: Mar 13, 5:00 PM EST

$2.96

-0.0528-1.75%

After Hours: Mar 13, 9:06 AM EST

Earnings: Q4 2025 Earnings in 9 days from now on Tue Mar 24th, before the market open

Overview NewsEarningsOptions Analyst Ratings Short Interest Stock Report

AC Immune Earnings Estimates, EPS & Revenue | NASDAQ:ACIU

AC Immune (ACIU) is scheduled to report Q4 earnings on March 24, 2026. Analysts estimate EPS of $-0.19 and quarterly revenue of $2.30M.

In the most recent quarter (Q3), AC Immune reported EPS of $-0.20, beating estimates of $-0.22 by 0.09%. Revenue came in at $1.17M, missing the estimate of $1.52M by 0.23%.

Over the last 4 quarters, AC Immune has averaged an EPS surprise of 0.10% and a revenue surprise of 1.11%.

Earnings Date

Mar 24

EPS Estimate

$-0.190

Quarterly Revenue Estimate

$2.30M

Annual Revenue

–

AC Immune Earnings History

Analyze the earnings history of AC Immune using advanced sorting and filters.

Loading calendar...

AC Immune (ACIU) Earnings Per Share

The chart below shows AC Immune's reported EPS compared to analyst estimates over recent quarters.

AC Immune (ACIU) Revenue

The chart below shows AC Immune's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is AC Immune (NASDAQ:ACIU) reporting earnings?

AC Immune (ACIU) is scheduled to report earnings on April 29, 2026. The last reported earnings were for reported on November 4, 2025 for Q3.

What were the latest earnings per share (EPS) for AC Immune (NASDAQ:ACIU)?

The Actual EPS was $-0.20, which beat the estimate of $-0.22.

What were AC Immune’s (NASDAQ:ACIU) revenues?

The Actual Revenue was $1.17M, which missed the estimate of $1.52M.

People Also Watch

Voyager Therapeutics Inc

Silence Therapeutics PLC

NASDAQ:SLN

$6.90

Fennec Pharmaceuticals Inc

NASDAQ:FENC

$7.91

5.19%

Abeona Therapeutics Inc

NASDAQ:ABEO

$4.76

Camp4 Therapeutics Corp

NASDAQ:CAMP

$5.21

-3.70%

Minerva Neurosciences Inc

NASDAQ:NERV

$7.70

-1.66%

AC Immune Earnings Estimates, EPS & Revenue | NASDAQ:ACIU

AC Immune (ACIU) is scheduled to report Q4 earnings on March 24, 2026. Analysts estimate EPS of $-0.19 and quarterly revenue of $2.30M.

In the most recent quarter (Q3), AC Immune reported EPS of $-0.20, beating estimates of $-0.22 by 0.09%. Revenue came in at $1.17M, missing the estimate of $1.52M by 0.23%.

Over the last 4 quarters, AC Immune has averaged an EPS surprise of 0.10% and a revenue surprise of 1.11%.

Earnings Date

Mar 24

EPS Estimate

$-0.190

Quarterly Revenue Estimate

$2.30M

Annual Revenue

–